Transient changes in the localization and activity of ecto-nucleotidases in rat hippocampus following lipopolysaccharide treatment

International Journal of Developmental Neuroscience

Volumn 25, Issue 5, 2007, Pages 275-282

  Kittel, Ágnes ^a   Sperlágh, Beata ^a   Pelletier, Julie ^b   Sévigny, Jean ^b   Kirley, Terence L ^c  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

ATP; Hippocampus; Lipopolysaccharide (LPS); Nucleoside triphosphate diphosphohydrolases (NTPDases); Purinergic signalling

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ECTO 5' NUCLEOTIDASE; ECTO NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; LIPOPOLYSACCHARIDE; NUCLEOTIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME LOCALIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LIPID MEMBRANE; MALE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD; APYRASE; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MALE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); RATTUS;

EID: 34447329557     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2007.05.007     Document Type: Article

References (60)

1. Anderson R.G. Caveolae: where incoming and outgoing messengers meet. Proc. Nat. Acad. Sci. USA 90 (1993) 10909-10913
2. Anderson R.G., and Jacobson K. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296 (2002) 1821-1825
3. Armulik A., Abramsson A., and Betsholtz C. Endothelial/pericyte interactions. Circ. Res. 97 (2005) 512-523
4. Atkinson B., Dwyer K., Enjyoji K., and Robson S.C. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: potential as therapeutic targets. Blood Cells Mol. Dis. 36 (2006) 217-222
5. Baraldi P.G., Di Virgilio F., and Romagnoli R. Agonists and antagonists acting at P2X7 receptor. Curr. Top. Med. Chem. 4 (2004) 1707-1717
6. Belcher S.M., Zsarnovszky A., Crawford P.A., Hemani H., Spurling L., and Kirley T.L. Immunolocalization of ecto-nucleoside triphosphate diphosphohydrolase 3 in rat brain: implications for modulation of multiple homeostatic systems including feeding and sleep-wake behaviors. Neuroscience 137 (2006) 1331-1346
7. Bianco F., Pravettoni E., Colombo A., Schenk U., Moller T., Matteoli M., and Verderio C. Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J. Immunol. 174 (2005) 7268-7277
8. Bigonnesse F., Levesque S.A., Kukulski F., Lecka J., Robson S.C., Fernandes M.J., and Sevigny J. Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. Biochemistry 43 (2004) 5511-5519
9. Braun N., Zhu Y., Krieglstein J., Culmsee C., and Zimmermann H. Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J. Neurosci. 18 (1998) 4891-4900
10. Braun N., Sevigny J., Robson S.C., Enjyoji K., Guckelberger O., Hammer K., Di Virgilio F., and Zimmermann H. Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain [In Process Citation]. Eur. J. Neurosci. 12 (2000) 4357-4366
11. Braun N., Sevigny J., Mishra S.K., Robson S.C., Barth S.W., Gerstberger R., Hammer K., and Zimmermann H. Expression of the ecto-ATPase NTPDase2 in the germinal zones of the developing and adult rat brain. Eur. J. Neurosci. 17 (2003) 1355-1364
12. Braun N., Sevigny J., Robson S.C., Hammer K., Hanani M., and Zimmermann H. Association of the ecto-ATPase NTPDase2 with glial cells of the peripheral nervous system. Glia 45 (2004) 124-132
13. Cunha R.A., Sebastiao A.M., and Ribeiro J.A. Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors. J. Neurosci. 18 (1998) 1987-1995
14. Derks R., and Beaman K. Regeneration and tolerance factor modulates the effect of adenosine triphosphate-induced interleukin 1 beta secretion in human macrophages. Hum. Immunol. 65 (2004) 676-682
15. Enjyoji K., Sevigny J., Lin Y., Frenette P.S., Christie P.D., Esch II J.S., Imai M., Edelberg J.M., Rayburn H., Lech M., Beeler D.L., Csizmadia E., Wagner D.D., Robson S.C., and Rosenberg R.D. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat. Med. 5 (1999) 1010-1017
16. Fausther M., Lecka J., Kukulski F., Lévesque S.A., Pelletier J., Zimmermann H., Dranoff J.A., and Sévigny J. Cloning, purification and identification of the liver canalicular ecto-ATPase as NTPDase8. Am. J. Physiol. Gastrointest. Liver Physiol. 292 (2007) G785-G795
17. Fernandez-Martinez E., Morales-Rios M.S., Perez-Alvarez V., and Muriel P. Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat. Biochem. Pharmacol. 68 (2004) 1321-1329
18. Ferrari D., Chiozzi P., Falzoni S., Hanau S., and Di Virgilio F. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185 (1997) 579-582
19. Grinthal A., and Guidotti G. Bilayer mechanical properties regulate the transmembrane helix mobility and enzymatic state of CD39. Biochemistry 46 (2007) 279-290
20. Hicks-Berger C.A., and Kirley T.L. Expression and characterization of human ecto-ATPase and chimeras with CD39 ecto-apyrase. IUBMB Life 50 (2000) 43-50
21. Imai M., Goepfert C., Kaczmarek E., and Robson S.C. CD39 modulates IL-1 release from activated endothelial cells. Biochem. Biophys. Res. Commun. 270 (2000) 272-278
22. Kaczmarek E., Koziak K., Sévigny J., Siegel J.B., Anrather J., Beaudoin A.R., Bach F.H., and Robson S.C. Identification and characterization of CD39 vascular ATP diphosphohydrolase. J. Biol. Chem. 271 (1996) 33116-33122
23. Kittel A. Distribution of Ca-ATPases in the medial habenula in mouse. Scanning Microsc. 8 (1994) 337-342
24. Kittel A. Lipopolysaccharide treatment modifies pH- and cation-dependent ecto-ATPase activity of endothelial cells. J. Histochem. Cytochem. 47 (1999) 393-400
25. Kittel A., and Bácsy E. Presynaptic ecto- and postsynaptic endo-calcium-adenosine-triphosphatases in synaptosomes: doubts about biochemical interpretation of localization. Int. J. Dev. Neurosci. 12 (1994) 207-211
26. Kittel A., Kaczmarek E., Sevigny J., Lengyel K., Csizmadia E., and Robson S.C. CD39 as a caveolar-associated ectonucleotidase. Biochem. Biophys. Res. Commun. 262 (1999) 596-599
27. Kittel A., Kalmár B., and Madarász E. Effects of LPS on ecto-ATPase (NTPDase) activity and phagocytosis of cultured astrocytes. In: Vanduffel L., and Lemmens R. (Eds). Proceedings of the Second International Workshop on Ecto-ATPases and Related Ecto-nucleotidases (1999), Shaker Publishing B.V., Maastricht, The Netherlands 158-166
28. Kittel A., Garrido M., and Varga G. Localization of NTPDase1/CD39 in normal and transformed human pancreas. J. Histochem. Cytochem. 50 (2002) 549-556
29. Kittel A., Csapo Z.S., Csizmadia E., Jackson S.W., and Robson S.C. Co-localization of P2Y1 receptor and NTPDase1/CD39 within caveolae in human placenta. Eur. J. Histochem. 48 (2004) 253-259
30. Kittel A., Pelletier J., Bigonnesse F., Guckelberger O., Kordas K., Braun N., Robson S.C., and Sevigny J. Localization of nucleoside triphosphate diphosphohydrolase-1 (NTPDase1) and NTPDase2 in Pancreas and salivary gland. J. Histochem. Cytochem. 52 (2004) 861-871
31. Kittel A., Kiss A.L., Mullner N., Matko I., and Sperlagh B. Expression of NTPDase1 and caveolins in human cardiovascular disease. Histochem. Cell Biol. 124 (2005) 51-59
32. Kordas K.S., Sperlagh B., Tihanyi T., Topa L., Steward M.C., Varga G., and Kittel A. ATP and ATPase secretion by exocrine pancreas in rat, guinea pig, and human. Pancreas 29 (2004) 53-60
33. Koziak K., Kaczmarek E., Kittel A., Sevigny J., Blusztajn J.K., Schulte Am Esch II J., Imai M., Guckelberger O., Goepfert C., Qawi I., and Robson S.C. Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae. J. Biol. Chem. 275 (2000) 2057-2062
34. Kukulski F., Lévesque S.A., Lavoie E.G., Lecka J., Bigonnesse F., Knowles A.F., Robson S.C., T.L. K., and Sévigny J. Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. Purinergic Signal. 1 (2005) 193-204
35. Kweon S.M., Wang B., Rixter D., Lim J.H., Koga T., Ishinaga H., Chen L.F., Jono H., Xu H., and Li J.D. Synergistic activation of NF-kappaB by nontypeable H. influenzae and S. pneumoniae is mediated by CK2, IKKbeta-IkappaBalpha, and p38 MAPK. Biochem. Biophys. Res. Commun. 351 (2006) 368-375
36. Li X., Shi X., Liang D.Y., and Clark J.D. Spinal CK2 regulates nociceptive signaling in models of inflammatory pain. Pain 115 (2005) 182-190
37. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
38. Maliszewski C.R., Delespesse G.J., Schoenborn M.A., Armitage R.J., Fanslow W.C., Nakajima T., Baker E., Sutherland G.R., Poindexter K., Birks C., Alpert A., Friend D., Gimpel S.D., and Gayle R.B. The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J. Immunol. 153 (1994) 3574-3583
39. Marcus A.J., Broekman M.J., Drosopoulos J.H., Islam N., Alyonycheva T.N., Safier L.B., Hajjar K.A., Posnett D.N., Schoenborn M.A., Schooley K.A., Gayle R.B., and Maliszewski C.R. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J. Clin. Invest. 99 (1997) 1351-1360
40. Meme W., Ezan P., Venance L., Glowinski J., and Giaume C. ATP-induced inhibition of gap junctional communication is enhanced by interleukin-1 beta treatment in cultured astrocytes. Neuroscience 126 (2004) 95-104
41. Moller T., Kann O., Verkhratsky A., and Kettenmann H. Activation of mouse microglial cells affects P2 receptor signaling. Brain Res. 853 (2000) 49-59
42. Nguyen K.T., Deak T., Owens S.M., Kohno T., Fleshner M., Watkins L.R., and Maier S.F. Exposure to acute stress induces brain interleukin-1beta protein in the rat. J. Neurosci. 18 (1998) 2239-2246
43. Pardridge W.M. Drug and gene targeting to the brain with molecular Trojan horses. Nat. Rev. 1 (2002) 131-139
44. Parhar K., Morse J., and Salh B. The role of protein kinase CK2 in intestinal epithelial cell inflammatory signaling. Int. J. Colorectal Dis. 22 (2007) 601-609
45. Pizzirani C., Ferrari D., Chiozzi P., Adinolfi E., Sandona D., Savaglio E., and Di Virgilio F. Stimulation of P2 receptors causes release of IL-1{beta}-loaded microvesicles from human dendritic cells. Blood 19 (2007) 3856-3869
46. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50 (1998) 413-492
47. Robson S.C., Wu Y., Sun X., Knosalla C., Dwyer K., and Enjyoji K. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin. Thromb. Hemost. 31 (2005) 217-233
48. Robson S.C., Sevigny J., and Zimmermann H. The E-NTPDase family of ectonucleotidases: structure, function, relationships and pathophysiological significance. Purinergic Signal. 2 (2006) 409-430
49. Schwencke C., Braun-Dullaeus R.C., Wunderlich C., and Strasser R.H. Caveolae and caveolin in transmembrane signaling: implications for human disease. Cardiovasc. Res. 70 (2006) 42-49
50. Sevigny J., Sundberg C., Braun N., Guckelberger O., Csizmadia E., Qawi I., Imai M., Zimmermann H., and Robson S.C. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 99 (2002) 2801-2809
51. Sperlagh B., Hasko G., Nemeth Z., and Vizi E.S. ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors. Neurochem. Int. 33 (1998) 209-215
52. Sträter N. Ecto-5′-nucleotidase: structure function relationships. Purinergic Signal. 2 (2006) 343-350
53. Suzuki T., Hide I., Ido K., Kohsaka S., Inoue K., and Nakata Y. Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J. Neurosci. 24 (2004) 1-7
54. Vlajkovic S.M., Housley G.D., Greenwood D., and Thorne P.R. Evidence for alternative splicing of ecto-ATPase associated with termination of purinergic transmission. Brain Res. Mol. Brain Res. 73 (1999) 85-92
55. Wang T.F., Ou Y., and Guidotti G. The transmembrane domains of ectoapyrase (CD39) affect its enzymatic activity and quaternary structure. J. Biol. Chem. 273 (1998) 24814-24821
56. Wang C.J., Vlajkovic S.M., Housley G.D., Braun N., Zimmermann H., Robson S.C., Sevigny J., Soeller C., and Thorne P.R. C-terminal splicing of NTPDase2 provides distinctive catalytic properties, cellular distribution and enzyme regulation. Biochem. J. 385 (2005) 729-736
57. Wink M.R., Braganhol E., Tamajusuku A.S., Lenz G., Zerbini L.F., Libermann T.A., Sevigny J., Battastini A.M., and Robson S.C. Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes. Neuroscience 138 (2006) 421-432
58. Wu J.J., Choi L.E., and Guidotti G. N-linked oligosaccharides affect the enzymatic activity of CD39: diverse interactions between seven N-linked glycosylation sites. Mol. Biol. Cell 16 (2005) 1661-1672
59. Xagorari A., Roussos C., and Papapetropoulos A. Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. Br. J. Pharmacol. 136 (2002) 1058-1064
60. Yamada M., Katsuma S., Adachi T., Hirasawa A., Shiojima S., Kadowaki T., Okuno Y., Koshimizu T.A., Fujii S., Sekiya Y., Miyamoto Y., Tamura M., Yumura W., Nihei H., Kobayashi M., and Tsujimoto G. Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis. Proc. Natl. Acad. Sci. USA 102 (2005) 7736-7741